Stem Cell Research to Provide New Equine Lameness Therapies

ViaGen, Inc. is partnering with the Monash Institute of Melbourne, Australia, to harness equine stem cells to repair tendon, ligament, cartilage, and bone damage in horses.

Dr. Paul Verma of the Monash Institute of Medical Research is

Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

ViaGen, Inc. is partnering with the Monash Institute of Melbourne, Australia, to harness equine stem cells to repair tendon, ligament, cartilage, and bone damage in horses.


Dr. Paul Verma of the Monash Institute of Medical Research is working to develop equine embryonic stem cell lines, with the goal of creating a “bank” of stem cells genetically matched to individual horses with no risk of rejection.


Current stem cell therapies use fat or bone marrow cells that are then grown into the required tissue cells. This process can take up to three weeks.


For more information, contact ViaGen; 12357-A Riata Trace Parkway, Suite 100, Austin, Texas 78727; 888/884-2436; www.viagen.com

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Where do you primarily feed your horse?
337 votes · 337 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!